Results 21 to 30 of about 74,134 (120)

Steeper memory decline after COVID-19 lockdown measures

open access: yesAlzheimer’s Research & Therapy, 2023
Background During COVID-19 lockdown measures, memory clinic patients reported worries for faster cognitive decline, due to loss of structure and feelings of loneliness and depression. We aimed to investigate the impact of the COVID-19 lockdown on rate of
Els D. Bakker   +7 more
doaj   +1 more source

The role of disability and depressive symptoms in the relation between objective cognitive performance and subjective cognitive decline

open access: yesFrontiers in Psychiatry, 2022
BackgroundSubjective cognitive decline (SCD) and subjective memory decline (SMD) are common among older people. Evidence linking SCD and SMD with cognitive and memory impairment is inconsistent. Moreover, little is known about the associations of SCD and
Deborah Pacifico   +3 more
doaj   +1 more source

A Homeostatic Model of Subjective Cognitive Decline

open access: yesBrain Sciences, 2018
Subjective Cognitive Decline (SCD) is possibly one of the earliest detectable signs of dementia, but we do not know which mental processes lead to elevated concern. In this narrative review, we will summarize the previous literature on the biomarkers and
Akiko Mizuno   +2 more
doaj   +1 more source

Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?

open access: yesDementia & Neuropsychologia
Background: Mild cognitive impairment is considered as the first clinical manifestation of Alzheimer's disease (AD), when the individual exhibits below performance on standardized neuropsychological tests.
Adalberto Studart Neto, Ricardo Nitrini
doaj   +1 more source

Symptom profiles and their influencing factors among people with subjective cognitive decline: a secondary analysis of cross-sectional data from the 2019 Korea Community Health Survey using latent class analysis

open access: yesBMJ Open, 2023
Objective Subjective cognitive decline, self-perceived cognitive deterioration without objective impairment, is becoming a vital health indicator, especially due to its intermediate stage between normal function and mild cognitive impairment.
Hohyun Seong, Jongmin Park
doaj   +1 more source

Impact of subjective cognitive decline on frailty in elderly patients with metabolic syndrome: the parallel mediating effects of physical activity and depression

open access: yes陆军军医大学学报
Objective Elderly patients with metabolic syndrome often present with concurrent subjective cognitive decline and frailty, yet the underlying mechanisms linking these conditions remain unclear.
WU Nuoy, XU Yuanchun
doaj   +1 more source

Cognitive Performance Among Older Adults with Subjective Cognitive Decline

open access: yesGeriatrics
Objectives: The main objective of this cross-sectional study was to investigate if there are significant differences in cognition between a group of older adults with subjective cognitive decline (SCD) and cognitively intact controls. Methods: An initial
Ramón López-Higes   +5 more
doaj   +1 more source

Memory-related subjective cognitive symptoms in the adult population: prevalence and associated factors – results of the LIFE-Adult-Study

open access: yesBMC Psychology, 2018
Background Subjectively perceived memory problems (memory-related Subjective Cognitive Symptoms/SCS) can be an indicator of a pre-prodromal or prodromal stage of a neurodegenerative disease such as Alzheimer’s disease.
Tobias Luck   +11 more
doaj   +1 more source

Bidirectional relationship between nocturnal subjective sleep duration and cognitive performance in Chinese over 45 years old: a national representative longitudinal study

open access: yesBMC Geriatrics, 2022
Introduction Previous studies have inconsistent associations between changes in sleep duration and cognitive function and have not separated interindividual effects from intraindividual effects.
Chao Li   +4 more
doaj   +1 more source

Subjective cognitive decline is a better marker for future cognitive decline in females than in males

open access: yesAlzheimer’s Research & Therapy, 2022
Background The identification of biomarkers for early detection of Alzheimer’s disease (AD) is critical to the development of therapies and interventions targeted at symptom management and tracking the pathophysiology of disease.
Michael D. Oliver   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy